Projects

WANIDA > Projects > Seroprevalence study of SARS-CoV-2 in North Central Nigeria using rapid diagnostic test

Title:
Seroprevalence study of SARS-CoV-2 in North Central Nigeria using rapid diagnostic test

The results of this study will influence policy decisions by the government, international development partners (IPS) and non-governmental organizations in the prevention and control of COVID 19 in Nigeria. It will also contribute to the body of knowledge by generating valuable information on the epidemiology of COVID 19 for future program evaluation.

WANIDA > Projects > Seroprevalence study of SARS-CoV-2 in North Central Nigeria using rapid diagnostic test


Serological tests are designed and validated for surveillance and research purposes. They are antibody tests that look for the presence of antibodies, which are specific proteins made in response to infections, in this case SARS-CoV-2 viruses.

The seroprevalence survey should estimate the prevalence of infection and exposure to SARS-CoV-2 in a population and can indicate the immune status of individuals or populations. In Nigeria, few seroprevalence surveys on SARS-CoV-2 have been conducted, including a pilot study in Niger State with only 85 participants. The study found a COVID 19 positivity rate of 25.41% and 2.16% for IgG and IgM positive respectively. Seroprevalence varied by age group, gender and occupation.

The level of screening for Covid-19 in many African countries in general, and in West Africa in particular, is generally considered to be inadequate, and figures reported by various national authorities do not accurately reflect the prevalence of the disease. The few seroprevalence studies have their limitations, a major limitation being that they were not population-based, with the exception of the unpublished survey conducted by the Nigeria Center for Disease Control in collaboration with the Nigerian Medical Research Institute. The proposed study is intended to address these and other issues.

Researchers:

  • Pr. Hussaini Anthony Makun, Professor of Biochemistry Centre Leader, Africa Centre of Excellence for Mycotoxin and Food Safety (ACEMFS)
  • Pr. Emmanuel O. Ogbadoyi, Professor of Biochemistry, ACEMFS

Funding: WANIDA

For more informatio : Olivia Koupaki, WANIDA Coordinator: olivia.koupaki@ird.fr /

By continuing your navigation on this site, you accept the use of cookies to allow us to offer you the best service.